Pilot Study: Feasibility and Usability of a Head-Mounted Spatial Computing Device for Intraoperative Visualization During Intraocular Surgery
1 other identifier
observational
70
1 country
1
Brief Summary
To evaluate the feasibility and usability of Apple Vision Pro as an adjunct visualization and information display tool during ophthalmic surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Aug 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 30, 2026
CompletedStudy Start
First participant enrolled
August 30, 2026
CompletedFirst Posted
Study publicly available on registry
September 17, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 30, 2028
September 17, 2026
September 1, 2026
1 year
August 30, 2026
September 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Continuity of care
Completion of surgery without device-related interruption that requires abandoning the surgery or conversion to an alternative procedure.
1 year
Questionnaire
XR Usability Questionnaire (XR-UQ) scores for each case.
1 year
Study Arms (1)
Patient undergoing cataract surgery
Cataract surgery patients
Interventions
Apple Vision Pro as an adjunct intraoperative visualization and information display tool during ophthalmic surgery.\[
Eligibility Criteria
Any patient having surgery performed who meets the inclusionary/exclusionary criteria at the Long Island Ambulatory Surgery Center, Brentwood, NY 11717
You may qualify if:
- Adults aged 18 years or older.
- Undergoing clinically indicated, elective ophthalmic surgery (e.g., cataract, anterior segment, retina) at a participating study site.
- Able and willing to provide informed consent prior to participation.
You may not qualify if:
- Prisoners or other vulnerable populations, unless specifically justified and approved by the IRB.
- Inability to provide consent and no legally authorized representative available.
- Cognitive impairment or language barriers precluding understanding of the consent, in the absence of a legally authorized representative.
- Procedures where any additional OR equipment is judged by the surgeon to pose unacceptable risk.
- Complex ocular pathology that could interfere with surgical visualization or increase procedural risk, including but not limited to lenticular zonule instability, previous ophthalmic surgery, corneal scarring, corneal opacity or edema, or active ocular surface infection.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Eric Rosenberglead
Study Sites (1)
Long Island Ambulator Surgery Center
Brentwood, New York, 11717, United States
Related Publications (1)
Orione M, Rubegni G, Tartaro R, Alberghina A, Fallico M, Orione C, Russo A, Tosi GM, Avitabile T. Utilization of apple vision pro in ophthalmic surgery: A pilot study. Eur J Ophthalmol. 2025 Mar;35(2):715-721. doi: 10.1177/11206721241273574. Epub 2024 Aug 14.
PMID: 39140319RESULT
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chief Medical Officer
Study Record Dates
First Submitted
August 30, 2026
First Posted
September 17, 2026
Study Start
August 30, 2026
Primary Completion (Estimated)
August 30, 2027
Study Completion (Estimated)
August 30, 2028
Last Updated
September 17, 2026
Record last verified: 2026-09
Data Sharing
- IPD Sharing
- Will not share
Novel technology with limited surgeons using 3D digital microscopes.